Brief: NFL Biosciences Raises Over EUR 3 Million

Nfl Biosciences SAS

31/01/2023 06:52

Jan 31 (Reuters) - Nfl Biosciences SAS  ALNFL.PA :
    * VERY SUCCESSFUL CAPITAL INCREASE FOR NFL BIOSCIENCES WITH
OVER
EUR 3 MILLION RAISED
    * STRONG SUCCESS OF PLACEMENT WITH PROFESSIONAL INVESTORS
WITH A
DIVERSIFIED BASE OF FRENCH AND INTERNATIONAL INVESTORS FOR AN
AMOUNT OF EUR 2.45 MILLION
    * EXCEPTIONAL PARTICIPATION OF RETAIL INVESTORS VIA
PRIMARYBID
PLATFORM WITH AN OFFER OVERSUBSCRIBED NEARLY 3 TIMES AND ALMOST
1,000 ORDERS RECEIVED, FOR A TOTAL AMOUNT OF EUR 1.6M, WITH EUR
0.6M BEING ALLOCATED TO RETAIL TRANCHE
    * SUBSCRIPTION PRICE SET AT EUR 2.23 PER NEW SHARE, IN
MIDDLE OF
OFFERING RANGE.
    * CASH HORIZON SECURED FOR MORE THAN 12 MONTHS, ALLOWING NFL
BIOSCIENCES TO REACH IN 2023 KEY MILESTONES OF TWO ONGOING
STUDIES ON NFL-101 AS A SMOKING CESSATION AID
    * SETTLEMENT AND DELIVERY OF NEW SHARES ON FEBRUARY 2, 2023

Source text for Eikon:  ID:nGNE32V8nj 
Further company coverage:  ALNFL.PA 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))